Skip to main content
SUZ
NYSE Manufacturing

Suzano S.A. Reports 2025 Financials, Announces New 40M Share Buyback Program, and Strategic Growth Initiatives

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
8
Price
$9.9
Mkt Cap
$12.348B
52W Low
$8.41
52W High
$10.41
Market data snapshot near publication time

summarizeSummary

Suzano S.A. released its comprehensive 2025 Management Report, detailing mixed financial results, strategic advancements including a new Kimberly-Clark joint venture, and the authorization of a significant new share buyback program for up to 40 million common shares.


check_boxKey Events

  • Mixed 2025 Financial Performance

    Reported R$50.1 billion in net revenue (up 6%), R$21.7 billion in Adjusted EBITDA (down 9%), and a net income of R$13.4 billion, reversing a loss from 2024. Net debt stood at US$12.6 billion, with financial leverage at 3.2x in USD.

  • New Share Buyback Program Authorized

    Announced a new program to acquire up to 40 million common shares, following the completion of a previous program that acquired 14.82 million shares for R$805 million. This new program represents a substantial capital allocation.

  • Strategic Growth and Competitiveness Initiatives

    Refined strategy around structural competitiveness and disciplined growth, including a 51% stake in a global tissue joint venture with Kimberly-Clark and positive EBITDA from U.S. paperboard assets acquired in late 2024.

  • Positive Credit Rating Outlooks

    Moody's reaffirmed Baa3 with a Positive outlook, while Fitch and S&P maintained BBB- ratings and upgraded their outlooks from Stable to Positive, reflecting expectations of a strengthened credit profile.


auto_awesomeAnalysis

Suzano S.A.'s 2025 Management Report provides a comprehensive overview of the company's performance and strategic direction. While Adjusted EBITDA saw a 9% decline and gross profit decreased by 19% year-over-year, the company successfully reversed its net loss from 2024 to report a net income of R$13.4 billion. Strategically, Suzano refined its focus on structural competitiveness and disciplined growth, highlighted by the acquisition of a 51% stake in a global tissue joint venture with Kimberly-Clark and positive performance from U.S. paperboard assets. A key market-moving event is the authorization of a new share buyback program for up to 40 million common shares, representing a significant capital allocation decision and a strong signal of management confidence, especially as the stock trades near its 52-week high. The company also received positive outlook upgrades from major credit rating agencies, further reinforcing its financial stability and strategic execution.

At the time of this filing, SUZ was trading at $9.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $12.3B. The 52-week trading range was $8.41 to $10.41. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SUZ - Latest Insights

SUZ
Apr 29, 2026, 5:02 PM EDT
Filing Type: 6-K
Importance Score:
8
SUZ
Apr 29, 2026, 5:01 PM EDT
Filing Type: 6-K
Importance Score:
8
SUZ
Apr 02, 2026, 5:13 PM EDT
Filing Type: 6-K
Importance Score:
8
SUZ
Mar 23, 2026, 6:32 PM EDT
Filing Type: 20-F
Importance Score:
9
SUZ
Mar 10, 2026, 9:32 PM EDT
Filing Type: 6-K
Importance Score:
7
SUZ
Mar 09, 2026, 9:09 PM EDT
Filing Type: 6-K
Importance Score:
8
SUZ
Mar 09, 2026, 9:04 PM EDT
Filing Type: 6-K
Importance Score:
7
SUZ
Feb 10, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
SUZ
Feb 10, 2026, 4:29 PM EST
Filing Type: 6-K
Importance Score:
8
SUZ
Feb 10, 2026, 4:27 PM EST
Filing Type: 6-K
Importance Score:
8